Literature DB >> 20079919

Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.

D Oh1, M J Jang, S J Lee, S Y Chong, M S Kang, H Wada.   

Abstract

BACKGROUND: The diagnostic performance of modified criteria for non-overt disseminated intravascular coagulation (DIC) with the addition of antithrombin (AT) levels, protein C (PC) levels, and organ system failure scoring (OSF) to the International Society on Thrombosis and Hemostasis (ISTH) criteria for non-overt DIC was studied to determine the effect on predicting poor outcome in patients with sepsis.
METHODS: In total, 135 consecutive patients were studied. Hemostatic markers (platelet count, prothrombin time, D-dimer, AT, PC) were examined on days 0, 1, 2, 3, 4, and 7. ISTH overt and non-overt DIC scoring, OSF, and 28-day mortality were analyzed.
RESULTS: The numbers of patients with overt DIC, non-overt DIC and non-DIC were 42, 17 and 76 respectively. The 28-day mortality rates for ISTH overt DIC, ISTH non-overt DIC, and non-DIC were 47.6, 47.1, and 9.2%, respectively. By adding AT and PC to the ISTH non-overt DIC criteria, the 28-day mortality rate of overt DIC, non-overt DIC, and non-DIC changed to 47.6, 25.0, and 6.7%, respectively. By adding OSF to the ISTH non-overt DIC criteria to predict 28-day mortality in septic patients, receiver operating characteristic (ROC) curve analysis demonstrated that the area under the curve (AUC) of ISTH non-overt DIC (0.777) was significantly increased to 0.878 (P=0.018). However, neither AT nor PC increased the AUC.
CONCLUSIONS: Addition of OSF to the ISTH criteria for non-overt DIC gives a better prediction of poor outcome in patients with sepsis. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079919     DOI: 10.1016/j.thromres.2009.12.008

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Tanshinone IIA protects rabbits against LPS-induced disseminated intravascular coagulation (DIC).

Authors:  Liang-Cai Wu; Xi Lin; Hao Sun
Journal:  Acta Pharmacol Sin       Date:  2012-09-17       Impact factor: 6.150

2.  Evidence of disseminated intravascular coagulation in a hemorrhagic fever with renal syndrome-scoring models and severe illness.

Authors:  Erik Sundberg; Johan Hultdin; Sofie Nilsson; Clas Ahlm
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

3.  Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation.

Authors:  Kyoung-Jin Park; Eui-Hoon Kwon; Hee-Jin Kim; Sun-Hee Kim
Journal:  Korean J Lab Med       Date:  2011-06-28

Review 4.  Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation.

Authors:  Toshiaki Iba; Daizoh Saitoh
Journal:  J Intensive Care       Date:  2014-12-31

5.  Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.

Authors:  Kansuke Koyama; Seiji Madoiwa; Shin Nunomiya; Toshitaka Koinuma; Masahiko Wada; Asuka Sakata; Tsukasa Ohmori; Jun Mimuro; Yoichi Sakata
Journal:  Crit Care       Date:  2014-01-13       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.